Various studies have also observed that cognitively normal individuals with APOE4 who exhibit higher baseline amyloid-beta accumulations, the hallmark AD protein pathology central to neurodegeneration and has been linked to gray matter alterations [22,49,50], demonstrate faster rates of cognitive decline in various cognitive processes over time [51–53]. Here, APOE is linked to Alzheimer disease.